Alphatec Spine Postpones 2013 Annual Meeting of Stockholders to June 21, 2013
and Supplements Proxy Statement
CARLSBAD, Calif., June 11, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc.
(Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device
company that designs, develops, manufactures and markets physician-inspired
solutions for patients with spinal disorders, today announced that it has
postponed its 2013 Annual Meeting of Stockholders, originally scheduled for
Monday, June 17, 2013. The Annual Meeting will now take place on Friday, June
21, 2013, at 2:00 P.M., Pacific Time at the Company's corporate headquarters,
which are located at 5818 El Camino Real, Carlsbad, CA 92008.
The Company also announced that it has supplemented its Proxy Statement for
the 2013 Annual Meeting to add a new proposal to approve an amendment to the
Alphatec Holdings, Inc. Amended and Restated 2005 Employee, Director and
Consultant Stock Plan to increase the per person annual award limit contained
in the Plan from 200,000 shares to 1,500,000 shares per year and to provide
additional disclosure with respect to certain other proposals in the Proxy
Statement. The Company postponed the Annual Meeting in order to provide
additional time for stockholders to review the additional proposal and revised
Formal notice of the rescheduled meeting, the Supplement to the Company's
Proxy Statement and new proxy cards are being mailed to the Company's
stockholders. More information on the Annual Meeting can be found in the
Company's Proxy Statement and the Supplement thereto, which are available in
the "Financial Information" section of the "Investor Relations" section of the
Company's website at www.alphatecspine.com, and on the website of the U.S.
Securities and Exchange Commission at www.sec.gov.
The record date for the Annual Meeting has not changed as a result of the
change in the meeting date. Stockholders of record at the close of business on
April 23, 2013 are entitled to notice of, and to vote at, the 2013 Annual
Meeting and any adjournment or postponement of the meeting. Stockholders are
encouraged to vote by telephone, the Internet or mail prior to the Annual
Meeting, whether or not they plan to attend the meeting. Stockholders who wish
to vote on the new proposal or change their votes on the other proposals must
submit a new proxy and will revoke all prior proxies by doing so. See the
information in the Company's Proxy Statement and the Supplement thereto
regarding voting procedures.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is
a medical device company that designs, develops, manufactures and markets
physician-inspired products and solutions for the treatment of spinal
disorders associated with trauma, congenital deformities, disease and
degeneration. The Company's mission is to combine innovative surgical
solutions with world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in the U.S.
and in over 50 countries internationally via a direct sales force and
independent distributors. Additional information can be found at
CONTACT: Investor/Media Contact:
Senior Director, Investor Relations
Alphatec Spine, Inc.
Press spacebar to pause and continue. Press esc to stop.